David I Pryor (David Pryor)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Radiation Therapy

Cone Beam Computed Tomography

Top Venues

BJU international

Journal of medical imaging and radiation oncology

Journal of medical radiation sciences

Physics in medicine and biology

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Ali, Young Suk Kwon, Kendrick Koo, Anna Bruynzeel, David I Pryor, Daniel G Schep, Michael Huo, Maggie Stein, Anand Swaminath, Raquibul Hannan, Shankar Siva
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer. BJU international (2024)
Trent A Pattenden, Isaac A Thangasamy, Wee Loon Ong, Dhanika Samaranayke, Andrew Morton, Declan G Murphy, Susan Evans, Jeremy L Millar, Venu Chalasani, Prem Rashid, Matthew Winter, Ian Vela, David I Pryor, Stephen Mark, Stacy Loeb, Nathan L Lawrentschuk, Elizabeth Pritchard
Barriers and enablers of active surveillance for prostate cancer - a qualitive study of clinicians. BJU international (2023)
Beini Chen, Nick Butler, Thomas O'Rourke, Peter Hodgkinson, Katherine Stuart, Edwin Shih, David Leggett, David I Pryor, Howard Yu-Hao Liu, Dominique Lee
Refining stereotactic body radiation therapy as a bridge to transplantation for hepatocellular carcinoma: An institutional experience. Journal of medical imaging and radiation oncology (2023)
Wee Loon Ong, Isaac A Thangasamy, Declan G Murphy, Elizabeth Pritchard, Susan Evans, Jeremy Millar, Venu Chalasani, Prem Rashid, Matthew Winter, Ian Vela, David I Pryor, Stephen Mark, Nathan L Lawrentschuk
Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand. BJU international (2022)
Benjamin Chua, Pereshin Moodaley, Wei Soon, Howard Yu-Hao Liu, Yoo Young Lee, David I Pryor
Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes. Journal of medical imaging and radiation oncology 65 (7) (2021)
Hang Min, Jason A Dowling, Michael G Jameson, Kirrily Cloak, Joselle Faustino, Mark Sidhom, Jarad Martin, Martin Andrew Ebert, Annette Haworth, Phillip Chlap, Jeremiah de Leon, Megan Berry, David I Pryor, Peter Greer, Shalini Kavita Vinod, Lois C Holloway
Automatic radiotherapy delineation quality assurance on prostate MRI with deep learning in a multicentre clinical trial. Physics in medicine and biology 66 (19) (2021)
Howard Yu-Hao Liu, Yoo-Young Dominique Lee, Swetha Sridharan, Ee Siang Choong, Hien Le, Wei Wang, Richard Khor, Julie Chu, Andrew Oar, Rebekah Mott, Joanne Smart, Trish Jenkins, Nigel Anderson, Shamira Cross, Kee Fong Loo, Alan Wigg, Katherine Stuart, David I Pryor
Stereotactic body radiotherapy in the management of hepatocellular carcinoma: An Australian multi-institutional patterns of practice review. Journal of medical imaging and radiation oncology 65 (3) (2021)
Rhys Fitzgerald, David I Pryor, Trent Aland, Lee Anderson, Marcel Knesl, Andrew Fong, Dominic Lunn, Andrew Oar, James Jackson, Matthew Foote
Quality and access - Early experience of implementing a virtual stereotactic chart round across a national network. Journal of medical imaging and radiation oncology 64 (3) (2020)
Elizabeth Brown, Erika Muscat, Patrick O'Connor, Howard Liu, Yoo-Young Lee, David I Pryor
Intrafraction cone beam computed tomography verification of breath hold during liver stereotactic radiation therapy. Journal of medical radiation sciences 68 (1) (2020)
Matthew John Roberts, Nathan Papa, Marlon Lakmal Perera, Susan Scott, Patrick E Teloken, Andre Joshi, Ian Vela, David I Pryor, Jarad Martin, Henry H Woo
A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer. BJU international (2019)
David I Pryor, Sandra L Turner, Keen Hun Tai, Colin Tang, Giuseppe Sasso, Marcus Dreosti, Henry H Woo, Lee Wilton, Jarad M Martin
Moderate hypofractionation for prostate cancer: A user's guide. Journal of medical imaging and radiation oncology 62 (2) (2018)
David I Pryor, Simon Wood
Stereotactic radiotherapy for primary renal cell carcinoma: time for larger-scale prospective studies. BJU international 120 (5) (2018)